KR20190012743A - Fish cake contained undenatured collagen type II and manufacturing method thereof - Google Patents
Fish cake contained undenatured collagen type II and manufacturing method thereof Download PDFInfo
- Publication number
- KR20190012743A KR20190012743A KR1020170096218A KR20170096218A KR20190012743A KR 20190012743 A KR20190012743 A KR 20190012743A KR 1020170096218 A KR1020170096218 A KR 1020170096218A KR 20170096218 A KR20170096218 A KR 20170096218A KR 20190012743 A KR20190012743 A KR 20190012743A
- Authority
- KR
- South Korea
- Prior art keywords
- collagen
- fish cake
- present
- fish
- ingredients
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract description 5
- 102000000503 Collagen Type II Human genes 0.000 title abstract 5
- 108010041390 Collagen Type II Proteins 0.000 title abstract 5
- 241000251468 Actinopterygii Species 0.000 claims abstract description 36
- 239000004615 ingredient Substances 0.000 claims abstract description 33
- 102000008186 Collagen Human genes 0.000 claims abstract description 32
- 108010035532 Collagen Proteins 0.000 claims abstract description 32
- 229920001436 collagen Polymers 0.000 claims abstract description 32
- 239000000203 mixture Substances 0.000 claims abstract description 30
- 235000013305 food Nutrition 0.000 claims abstract description 16
- 239000000463 material Substances 0.000 claims abstract description 14
- 239000002131 composite material Substances 0.000 claims abstract description 13
- 235000013372 meat Nutrition 0.000 claims abstract description 4
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 241000195940 Bryophyta Species 0.000 claims description 12
- 235000011929 mousse Nutrition 0.000 claims description 12
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 6
- 244000061456 Solanum tuberosum Species 0.000 claims description 6
- 244000017020 Ipomoea batatas Species 0.000 claims description 5
- 235000002678 Ipomoea batatas Nutrition 0.000 claims description 5
- 239000008194 pharmaceutical composition Substances 0.000 claims description 2
- 240000007594 Oryza sativa Species 0.000 claims 2
- 235000007164 Oryza sativa Nutrition 0.000 claims 2
- 235000013312 flour Nutrition 0.000 claims 2
- 235000009566 rice Nutrition 0.000 claims 2
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 239000012876 carrier material Substances 0.000 claims 1
- 210000000845 cartilage Anatomy 0.000 abstract description 23
- 239000000843 powder Substances 0.000 abstract description 22
- 206010003246 arthritis Diseases 0.000 abstract description 17
- 241000287828 Gallus gallus Species 0.000 abstract description 12
- 230000036541 health Effects 0.000 abstract description 7
- 238000000034 method Methods 0.000 abstract description 7
- 230000003712 anti-aging effect Effects 0.000 abstract description 4
- 239000008157 edible vegetable oil Substances 0.000 abstract description 2
- 230000037213 diet Effects 0.000 abstract 1
- 235000005911 diet Nutrition 0.000 abstract 1
- 239000006049 herbal material Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 16
- 235000012907 honey Nutrition 0.000 description 14
- 244000291564 Allium cepa Species 0.000 description 12
- 210000000038 chest Anatomy 0.000 description 12
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 11
- 235000013330 chicken meat Nutrition 0.000 description 11
- 201000010099 disease Diseases 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 210000003491 skin Anatomy 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 206010040954 Skin wrinkling Diseases 0.000 description 9
- 210000001503 joint Anatomy 0.000 description 9
- 230000032683 aging Effects 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 230000005764 inhibitory process Effects 0.000 description 8
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 7
- 108010003272 Hyaluronate lyase Proteins 0.000 description 7
- 102000001974 Hyaluronidases Human genes 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 7
- 235000014676 Phragmites communis Nutrition 0.000 description 7
- 210000000988 bone and bone Anatomy 0.000 description 7
- 229920002674 hyaluronan Polymers 0.000 description 7
- 229960003160 hyaluronic acid Drugs 0.000 description 7
- 229960002773 hyaluronidase Drugs 0.000 description 7
- 230000004054 inflammatory process Effects 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 6
- 235000013399 edible fruits Nutrition 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 230000037303 wrinkles Effects 0.000 description 6
- 235000006679 Mentha X verticillata Nutrition 0.000 description 5
- 235000002899 Mentha suaveolens Nutrition 0.000 description 5
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 229910052500 inorganic mineral Inorganic materials 0.000 description 5
- 239000011707 mineral Substances 0.000 description 5
- 239000011812 mixed powder Substances 0.000 description 5
- 201000008482 osteoarthritis Diseases 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 241000759833 Cornus officinalis Species 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 241000222336 Ganoderma Species 0.000 description 4
- 208000008589 Obesity Diseases 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000000470 constituent Substances 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 210000000987 immune system Anatomy 0.000 description 4
- 235000020824 obesity Nutrition 0.000 description 4
- 230000037394 skin elasticity Effects 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 235000017060 Arachis glabrata Nutrition 0.000 description 3
- 244000105624 Arachis hypogaea Species 0.000 description 3
- 235000010777 Arachis hypogaea Nutrition 0.000 description 3
- 235000018262 Arachis monticola Nutrition 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 235000015459 Lycium barbarum Nutrition 0.000 description 3
- 244000241838 Lycium barbarum Species 0.000 description 3
- 241000382353 Pupa Species 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 235000005687 corn oil Nutrition 0.000 description 3
- 239000002285 corn oil Substances 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 210000002414 leg Anatomy 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 235000020232 peanut Nutrition 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 235000016413 Actinidia polygama Nutrition 0.000 description 2
- 240000006274 Actinidia polygama Species 0.000 description 2
- 235000010167 Allium cepa var aggregatum Nutrition 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 2
- 240000008397 Ganoderma lucidum Species 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 244000246386 Mentha pulegium Species 0.000 description 2
- 235000016257 Mentha pulegium Nutrition 0.000 description 2
- 235000004357 Mentha x piperita Nutrition 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 241000736199 Paeonia Species 0.000 description 2
- 235000006484 Paeonia officinalis Nutrition 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 244000305267 Quercus macrolepis Species 0.000 description 2
- 206010057190 Respiratory tract infections Diseases 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- 235000006886 Zingiber officinale Nutrition 0.000 description 2
- 244000273928 Zingiber officinale Species 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 210000001188 articular cartilage Anatomy 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 235000021152 breakfast Nutrition 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000003848 cartilage regeneration Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- RZEKVGVHFLEQIL-UHFFFAOYSA-N celecoxib Chemical compound C1=CC(C)=CC=C1C1=CC(C(F)(F)F)=NN1C1=CC=C(S(N)(=O)=O)C=C1 RZEKVGVHFLEQIL-UHFFFAOYSA-N 0.000 description 2
- 229960000590 celecoxib Drugs 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 210000001508 eye Anatomy 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 235000008397 ginger Nutrition 0.000 description 2
- 229940102465 ginger root Drugs 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 235000001050 hortel pimenta Nutrition 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 208000027866 inflammatory disease Diseases 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 208000018937 joint inflammation Diseases 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 231100000544 menstrual irregularity Toxicity 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 208000015122 neurodegenerative disease Diseases 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000000803 paradoxical effect Effects 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 235000019157 thiamine Nutrition 0.000 description 2
- 239000011721 thiamine Substances 0.000 description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- 210000002303 tibia Anatomy 0.000 description 2
- 210000000689 upper leg Anatomy 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 239000001841 zingiber officinale Substances 0.000 description 2
- LGJMUZUPVCAVPU-ANOYILKDSA-N (3s,8r,9s,10s,13r,14s,17r)-17-[(2r,5s)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-ol Chemical class C1CC2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@H](CC)C(C)C)[C@@]1(C)CC2 LGJMUZUPVCAVPU-ANOYILKDSA-N 0.000 description 1
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- BGNGWHSBYQYVRX-UHFFFAOYSA-N 4-(dimethylamino)benzaldehyde Chemical compound CN(C)C1=CC=C(C=O)C=C1 BGNGWHSBYQYVRX-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 244000167222 Acanthopanax sessiliflorus Species 0.000 description 1
- 235000017615 Acanthopanax sessiliflorus Nutrition 0.000 description 1
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 244000298697 Actinidia deliciosa Species 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 206010052613 Allergic bronchitis Diseases 0.000 description 1
- 240000006108 Allium ampeloprasum Species 0.000 description 1
- 235000005254 Allium ampeloprasum Nutrition 0.000 description 1
- 235000005255 Allium cepa Nutrition 0.000 description 1
- 235000011645 Allium x proliferum Nutrition 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000256837 Apidae Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 241000224466 Giardia Species 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 244000241872 Lycium chinense Species 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010028289 Muscle atrophy Diseases 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 description 1
- 244000236658 Paeonia lactiflora Species 0.000 description 1
- 206010033372 Pain and discomfort Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 241001505102 Valeriana fauriei Species 0.000 description 1
- 208000024248 Vascular System injury Diseases 0.000 description 1
- 208000035868 Vascular inflammations Diseases 0.000 description 1
- 208000012339 Vascular injury Diseases 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 208000008445 altitude sickness Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- 239000002956 ash Substances 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 150000001508 asparagines Chemical class 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000003321 cartilage cell Anatomy 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 208000023819 chronic asthma Diseases 0.000 description 1
- 229930007050 cineol Natural products 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 230000003366 colagenolytic effect Effects 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 229920002055 compound 48/80 Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000005786 degenerative changes Effects 0.000 description 1
- 230000003413 degradative effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 244000013123 dwarf bean Species 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 235000021321 essential mineral Nutrition 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 229940014144 folate Drugs 0.000 description 1
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000018191 liver inflammation Diseases 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- 150000002773 monoterpene derivatives Chemical class 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 230000020763 muscle atrophy Effects 0.000 description 1
- 230000036640 muscle relaxation Effects 0.000 description 1
- 201000000585 muscular atrophy Diseases 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 244000080466 oignon Species 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000036581 peripheral resistance Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- -1 pinene Chemical compound 0.000 description 1
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000013138 pruning Methods 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 229940083492 sitosterols Drugs 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 235000021012 strawberries Nutrition 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001694 thigh bone Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000006163 transport media Substances 0.000 description 1
- WUUHFRRPHJEEKV-UHFFFAOYSA-N tripotassium borate Chemical compound [K+].[K+].[K+].[O-]B([O-])[O-] WUUHFRRPHJEEKV-UHFFFAOYSA-N 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/70—Comminuted, e.g. emulsified, fish products; Processed products therefrom such as pastes, reformed or compressed products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
- A23L19/12—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops of potatoes
- A23L19/13—Mashed potato products
- A23L19/135—Preformed edible shells filled with mashed potatoes; Stuffed mashed potato products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P20/00—Coating of foodstuffs; Coatings therefor; Making laminated, multi-layered, stuffed or hollow foodstuffs
- A23P20/20—Making of laminated, multi-layered, stuffed or hollow foodstuffs, e.g. by wrapping in preformed edible dough sheets or in edible food containers
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/54—Proteins
- A23V2250/542—Animal Protein
- A23V2250/5422—Collagen
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Health & Medical Sciences (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
본 발명은 노화 및 관절염의 예방효과가 있는 닭흉부연골 추출분말과 한방재료가 포함된 속재료와 속재료를 감싸는 연육반죽 또는 어묵살에 관한 것으로서, 보다 구체적으로 속재료에는 닭흉부연골 추출분말과 꿀,진피, 당귀, 창출, 길초근, 감초, 갈근, 복령, 박하, 치자를 포함하며, 속재료를 감싸고 고열의 식용기름이 직접 속재료에 닿는 것을 방지하고 식재료로서 효용성이 높은 연육반죽을 사용하여 대중적으로 손쉽게 먹을 수 있는 어묵을 제조하는 방법에 관한 것이다.The present invention relates to chick chest cartilage extract powder having a preventive effect against aging and arthritis, and a raw material containing a herbal ingredient and a meat dough or fish paste flesh wrapped around the ingredient. More specifically, the ingredients include chicken chest cartilage extract powder, honey, It contains the ingredients, prevents the high-temperature edible oil from directly touching the ingredients, and uses the potato dough, which is highly effective as a food material, to be easily eaten by the public. The present invention relates to a method of manufacturing a fish paste which can be used as a fish paste.
최근 노령인구의 전유물로 여겨지던 당뇨, 고혈압 등의 생활습관질환과 치매, 관절염, 동맥경화 등의 퇴행성 질환이 증가하고, 발병 연령이 점진적으로 낮아지고 광범위해지면서 일반적인 질환으로 인식되고 있다. 노화현상을 예방하고 퇴행성질환의 초기 증상을 제거/조기 치료하면서 질병없이 건강하게 살고 싶은 욕구는 모든 분야의 연구 동력이 되고 있다. Recently, lifestyle diseases such as diabetes and hypertension, degenerative diseases such as dementia, arthritis and arteriosclerosis, which are regarded as the exclusive items of the elderly population, are increasingly recognized as a general disease as the age of onset gradually decreases and becomes widespread. The desire to prevent aging and eliminate the early symptoms of degenerative diseases / early treatment and to live healthy without disease has become a research force in all fields.
노화 현상을 세포수준의 생물학적 관점에서 보면 유해산소와 콜라겐 분해효소가 핵심요인으로 파악된다. 유해산소는 세포막 지질을 공격하여 손상된 세포막에 의한 피부세포가 정상적인 역할을 할 수 없게 작용한다. 콜라겐 분해효소의 증가는 섬유 변성과 파괴에 의해 관절염 질환과 깊은 관련이 있으며 주름 발생에 중요한 원인이 되는 것으로 보인다.From the biological point of view of cell level, the harmful oxygen and collagenase are considered to be the key factors of aging. The harmful oxygen attacks the cell membrane lipids and prevents the skin cells from being damaged by the damaged cell membranes. Increases in collagenolytic enzymes are related to arthritic disease by fiber degeneration and destruction, and appear to be an important cause of wrinkles.
어묵은 저열량 고품질의 단백질을 간편하게 섭취할 수 있는 대중적인 식품이다. 다양한 어묵의 종류와 형태 중에서 어묵 속에 다른 식재료를 포함하는 만두 개념의 어묵의 경우 겉껍질에 사용되는 어묵과 속의 식재료 모두를 동시에 고열로 익히고 있다.Fish cake is a popular food that can easily ingest a low calorie high quality protein. Among various types and forms of fish paste, fish paste which includes other ingredients in fish paste has both fish paste and inner ingredients used in the shell.
노화는 대표적인 생명현상의 하나로 시간의 경과에 따라 신체가 겪는 모든 생리적 변화를 통칭하기도 한다. 암, 심혈관계 질환, 비만, 지방간 등 많은 질환은 기본적으로 세포와 개별 장기와 기관의 기능저하 현상과 관련이 깊고 이것을 질병으로 볼 것인지 노화의 과정으로 볼 것인지는 의학적으로 깊은 논의가 진행되고 있는 실정이다.Aging is one of the representative life phenomena, and it refers to all the physiological changes that the body undergoes over time. Many diseases such as cancer, cardiovascular disease, obesity and fatty liver are basically related to the deterioration of cells and individual organs and organs, and there is a deep discussion about whether this is regarded as a disease or aging process. .
노화와 관련이 깊은 대표적인 질환 중의 하나로 한국 인구의 5%가 만성적 관절염을 앓고 있으며, 관절염이라는 질병명으로 진단받지 않은 절대 다수의 고령층이 관절과 관련한 통증과 불편을 겪고 있다. 관절염이 유발되는 직접적인 원인은 아직 분명하게 알려진바가 없지만, 염증성 매개체들과 사이토카인(cytokine)의 국소적인 방출과 함께 T 세포가 중요한 역할을 하여 결과적으로 관절을 파괴하는 지속적인 자가면역반응으로 나타난다. 피로, 무력감, 동통 등을 호소하며, 관절염이 진행되면서 발열 및 체력쇠약을 동반한다. 또한 염증이 일어난 관절 부근에 근육강직(muscle atrophy)과 근육경축(muscle spasm)이 나타나 관절의 움직임에 영향을 준다.As one of the representative diseases related to aging, 5% of the Korean population suffers from chronic arthritis, and a large number of elderly people who are not diagnosed with the disease name of arthritis suffer pain and discomfort related to joints. The direct cause of arthritis is not yet clear, but T cells play an important role in inflammatory mediators and local release of cytokines, resulting in a sustained autoimmune reaction that destroys the joints. Fatigue, helplessness, and pain, arthritis is accompanied by fever and physical weakness. In addition, muscle atrophy and muscle spasm appear near the inflamed joints, affecting movement of the joints.
치료를 위해서 코르티손, 부신피질 호르몬, 스테로이드계 약물과 아스피린, 피록시캄이나 인도메타신과 같은 비스테로이드계 항염증제 등의 다양한 화학적 치료제가 사용되고 있다. 이러한 화학적 치료제들은 근본적인 치료 효과가 없으며, 통증을 완화시키고 염증을 일시적으로 제거하는 역할을 하지만 위장에 큰 부담을 주기 때문에 통증완화를 위해 필요한 양을 지속적으로 장기간 복용하는 것은 어렵다.Various therapeutic agents such as cortisone, corticosteroids, steroid drugs and non-steroidal anti-inflammatory drugs such as aspirin, pyroxycam and indymethacin have been used for the treatment. These chemotherapeutic agents have no fundamental therapeutic effect, they relieve pain and temporarily eliminate inflammation, but because they put a heavy burden on the stomach, it is difficult to take the amount needed for pain relief continuously for a long time.
비변성 2형 콜라겐은 콜라겐 특유의 구조 변화가 거의 없이 위장관내 소화가 이루어져 소장 내 면역기관까지 흡수율이 아주 높다. 이러한 비변성 2형 콜라겐은 70~80%의 수분을 제외한 연골 구성 물질의 대부분을 차지하는 콜라겐으로 관절 연골 재생 효과가 있다. 또한 닭흉부연골 추출분말, 벌꿀, 양파, 갈대 뿌리, 구기자 열매, 개다래나무 열매, 박하, 길초근, 갈근, 산수유 열매, 작약 뿌리, 오갈피나무 뿌리 등의 천연물들은 전통적으로 1000년 이상 관절염과 염증치료에 이용되어 왔으며, 최근의 의학연구에 의해 그 효과와 기능으로 실질적인 질병치료연구에 사용되고 있다.Non-denatured type 2 collagen is highly absorbed up to the intestinal immune system by digestion in the gastrointestinal tract with little structural change of collagen. This non-modified type 2 collagen has a cartilage regeneration effect with collagen which occupies most of the cartilage constituent material except for 70 ~ 80% moisture. Natural products such as chickens chest cartilage extract powder, honey, onion, reed roots, goji berries, ganoderma, mint, gill root, purlins, corn oil, peanut roots and oak root roots have traditionally been treated for over a thousand years for arthritis and inflammation And has been used in practical disease treatment research with its effects and functions by recent medical researches.
본 발명은 관절염을 비롯한 각종 염증질환에 효과가 있는 천연복합재료와 체내 콜라겐 구조와 가장 가까운 비변성 제2형 콜라겐의 조성물을 속재료로 사용하고 속재료를 보호하는 겉껍질로 어묵을 사용하여 식품의 형태로 섭취할 수 있도록 하는 방법으로서 본 발명에 사용된 천연물들에 대해 간략하게 설명하면 다음과 같다.The present invention relates to a composition comprising a natural composite material effective for various inflammatory diseases including arthritis and a composition of non-modified type 2 collagen closest to the collagen structure in the body, as a starting material, and using fish cake as a crust for protecting the ingredient, The natural products used in the present invention will be briefly described as follows.
닭흉부연골 추출분말(Chicken sternal cartilage extract powder)은 콜라겐의 여러구조 중 2형 타입에 해당하는 콜라겐이 주요 구성물이다. 콜라겐은 단백질, 콘드로이틴황산, 수분, 인, 회분 등으로 구성되어 있는 생체의 주요 구성 단백질 중 하나로서 피부나 관절 연골의 주요한 구성물질이고 인대, 뼈, 혈관 등 인체 조직의 넓은 분포를 차지하고 있다. 생체 내 분포 또는 속성에 따라 1, 2, 3형에서 20형 까지 분류하고 있다. 관절의 주성분은 수분을 제외하면 대부분 2형 콜라겐이다. 2형 콜라겐은 연골의 윤활유 역할을 해주는 물질이며 조직내에서 수분을 결합시켜 관절의 운동을 도와주는 역할을 하여 골관절염과 류마티스 관절염의 통증을 완화시키고 인체 각 관절의 연골 퇴행을 지연시킨다는 연구결과가 다수 보고되어 있다. 콜라겐은 음식으로 많이 섭취할 수 있지만 분자가 크고 섭취된 콜라겐이 소화기에서 아미노산으로 분해되어 콜라겐이 필요한 관절과 연골조직까지 도달하지 못한다. 비변성 2형 콜라겐은 체내에서 거의 형태 그대로 소장까지 도착하는 유용물질로 인식되어 돼지껍데기나 족발의 형태로 섭취되는 변성콜라겐에 비해 높은 기능성을 보인다.Chicken sternal cartilage extract powder is a major constituent of collagen, which corresponds to the type 2 type of collagen. Collagen is one of the major constituent proteins of proteins, chondroitin sulfate, water, phosphorus, and ash. It is a major constituent of skin or articular cartilage and occupies a wide distribution of human tissues such as ligaments, bones, and blood vessels. It is classified into types 1, 2, 3 to 20 according to in vivo distribution or property. The major component of joints is type 2 collagen, except for water. Type 2 collagen acts as a lubricant for cartilage, and it plays a role in helping movements of joints by binding moisture in tissues, thereby relieving the pain of osteoarthritis and rheumatoid arthritis, and delaying cartilage regression of human joints. Reported. Collagen can be consumed as much as food, but collagen, which is a large molecule and consumed, is decomposed from the digestive tract into amino acids and collagen does not reach joints and cartilage tissues. Non-denatured type 2 collagen is recognized as a useful substance that reaches the small intestine in almost the form in the body and shows higher functionality than denatured collagen ingested in the form of pig shell or foot.
벌꿀(honey)은 지난 2,500년 동안 대부분의 문화에서 건강, 미용, 의약적 목적으로 사용되어 왔다. 69%의 포도당과 과당을 함유하고 있어 백설탕보다 건강에 이로운 감미료로 사용할 수 있으며, 운동 후 혈당회복, 근육회복, 글리코겐 복원을 돕는다. 높은 수준의 미네랄과 비타민이 함유되어 있으며, 항균과 항진균 성질이 뛰어나 천연 방부제로 사용된다.Honey has been used for health, beauty and medical purposes in most cultures for the last 2,500 years. It contains 69% glucose and fructose. It can be used as a sweetener which is healthier than white sugar. It helps recovery of blood glucose, recovery of muscle, and glycogen restoration after exercise. It contains high levels of minerals and vitamins. It has excellent antibacterial and antifungal properties and is used as a natural preservative.
양파(학명 Allium cepa, 영문 onion)은 부추속에 속한 양파 중에서도 영어로 garden onion, bulb onion, shallot이라고 부르는 것을 말한다. 고대부터 치유효과가 있는 것으로 알려져 있으며 5000년 이상 인류와 함께 해왔다. 감기, 천식, 세균 감염, 호흡기 질환, 협심증 및 기침을 비롯한 여러 질병을 실질적으로 완화시키는 역할을 포함한다. 합니다. 세계 보건기구 (WHO)조차도 식욕이 감소한 사람들과 염증증상을 앓고있는 사람들에게 유익하다는 것을 확인하고 있다. 만성 천식, 알레르기성 기관지염, 감기에 관련된 일반적인 기침 및 감기 증후군 환자 등 면역계통 보호와 염증극복에 효과가 있다.Onion (Allium cepa, English onion), among the onion belonging to the leek, it is what we call garden onion, bulb onion, shallot in English. It has been known to have healing effects from ancient times and has been with humanity for over 5,000 years. Cold, asthma, bacterial infections, respiratory diseases, angina, and cough. I will. Even the World Health Organization (WHO) has confirmed that it is beneficial to people with reduced appetite and people with inflammatory symptoms. Chronic asthma, allergic bronchitis, common cough related to colds, and cold syndrome patients are effective in protecting the immune system and overcoming inflammation.
갈대 뿌리(노근, 학명 hragmites australis, 영문 reed root)는 최근 신경전달물질인 아세틸콜린을 합성하는 강력한 성분이 발견되어 노화억제성분으로 활용하기 위한 연구가 활발히 진행되고 있다. 전통적으로 구토, 비뇨기계통, 관절염과 같은 질환에 사용해왔다. 봄에서 가을에 채취하여 말려서 차로 끓이거나 약제로 사용한다. 강한 살균작용으로 각종 염증에 효과적이다.The reed roots (nogeun, hragmites australis, reed root in English) have recently been found to be powerful components for synthesizing acetylcholine, a neurotransmitter, and are being actively studied for use as aging inhibitors. Traditionally, it has been used for diseases such as vomiting, urinary system and arthritis. It is harvested in spring and autumn, dried, boiled or used as a medicine. It is effective against various inflammation with strong sterilizing action.
구기자 열매(학명 Lycium chinense, 영문 Matrimony vine)는 고대부터 에너지와 힘을 회복하고 체력과 수명을 늘리는 열매로 알려져있다. 식물 중에서 두 번째로 풍부한 비타민 C 공급원이며 희귀 게르마늄을 포함한 21 가지 필수 미네랄과 18 가지 아미노산을 함유하고 있다. 수퍼푸드라고 알려진 주요한 식물들에서 발견되는 항산화 물질의 약 5배 수준이다. 약간의 소염제 성분과 체지방감소에 도움이 되는 리놀레산 등의 필수 지방산, 심장과 혈압 유지에 기여하는 다당류, 면역계 밸런스 유지에 도움이 되는 성장 호르몬과 항 박테리아 화합물(solavetivone)도 발견된다.Lycium chinense (English name: Matrimony vine) has been known since ancient times as a fruit that regains energy and strength, and increases physical strength and longevity. It is the second most abundant source of vitamin C in plants and contains 21 essential minerals, including rare germanium, and 18 amino acids. It is about five times the level of antioxidants found in major plants known as superfoods. Some anti-inflammatory ingredients, essential fatty acids such as linoleic acid to help reduce body fat, polysaccharides that contribute to heart and blood pressure maintenance, and growth hormones and anti-bacterial compounds that help maintain the balance of the immune system.
개다래나무(학명 Actinidia polygama, 영문 Silver vine)의 열매는 아시아 지역에서 수세기 동안 예방용 건강 보조 식품으로 고혈압, 관절염 통증을위한 대체 요법으로 흔히 사용되었다. 플라 보노이드, 테르페노이드, 사포닌, 베타 카로틴, 알칼로이드가 많이 함유 되어있다.비타민 C의 함량은 녹차보다 10 배 높으며 딸기, 키위, 블루 베리, 레몬과 같은 과일 종보다 훨씬 높다. 류마티스 관절염의 치료 및 관절염의 통증 완화에 사용되는 개다래나무 열매의 항염증 특성은 폐의 염증과 항암연구에 사용되고 있다.The fruit of the genus Jupiter (Scientific name Actinidia polygama, English silver vine) has been used for centuries as a preventative health supplement in Asia for hypertension and alternative therapies for arthritis pain. Vitamin C is 10 times higher than green tea and is much higher than fruit varieties such as strawberries, kiwi, blueberries and lemons. The antiinflammatory properties of giardia officinalis, which is used to treat rheumatoid arthritis and alleviate arthritis pain, are used in lung inflammation and anticancer studies.
박하(학명 Mentha canadensis, 영문 Menthae Herba). 호흡기 건강과 소화 기능을 돕는다. 호르몬 불균형으로 인한 다양한 증후군을 치료하는데 사용되기도 하며, 높은 철분함량으로 적혈구 및 헤모글로빈 생산을 촉진해서 에너지 레발과 상처 치유 능력을 향상시킨다. 리모넨, 시네올, 피넨, 비타민 A, 비타민 C, 리보플라빈 및 티아민, 산화 방지제는 건강한 세포를 공격하는 산화물질에 의해 유발되는 암을 비롯한 만성 질병을 예방하는 강력한 도구가 된다.Mint (Menthae canadensis, English Menthae Herba). Helps in respiratory health and digestion. It is also used to treat various syndromes due to hormonal imbalance. It promotes red blood cell and hemoglobin production with high iron content and improves energy regal and wound healing ability. Limonene, cineol, pinene, vitamin A, vitamin C, riboflavin and thiamine, and antioxidants are powerful tools to prevent chronic diseases, including cancer, caused by oxidants that attack healthy cells.
길초근(쥐오줌풀, 학명 Valeriana fauriei)은 동속근연식물로 좀쥐오줌풀, 넓은잎쥐오줌풀, 광릉쥐오줌풀 등이 있으며 모두 약재로 사용되는데 특이한 냄새가 있다. 2세기부터 유럽에서 불안과 신경상태 치료를 위해 널리 사용되었다. 특히 최근에는 수면의 질 향상을 위한 약제의 하나로서 많은 연구가 이루어지고 있으며 고산병, 생리불순, 위경련, 관절염, 타박상 등에도 사용한다. 약리작용으로 진정작용, 진경작용, 혈압강하, 그람양성균 억제작용, 이뇨작용 등이 보고되어 있다.Valeriana fauriei is a relative plant belonging to the same genus. It has a small pupa, broad leaf pupa, and a giant pupa. They are all used as medicinal materials and have a peculiar smell. From the second century on, it was widely used in Europe for the treatment of anxiety and neurological conditions. Recently, many studies have been made as one of the medicines for improving the quality of sleep, and they are also used for altitude sickness, menstrual irregularities, stomach cramps, arthritis, bruises. Pharmacological actions have been reported for sedation, antipyretic action, hypotension, inhibition of Gram-positive bacteria, and diuretic action.
갈근은 칡(학명 Pueraria lobata, 영문 Puerariae Radix) 뿌리의 껍질로 냄새가 없다. 체내의 열을 내리고 독성물질을 제거하는 모적으로 아시아 지역에서 1000년 이상 사용되어 왔다. 혈관을 직접 팽창시키고 말초 저항을 감소시켜 혈압을 낮추고 고혈압 환자의 경직된 증상을 완화한다. 최근의 연구에서는 항암 및 에스트로겐 유사 효과가 있어 자연적인 유방확대 및 미용 제품으로 사용할 수 있어 중년 여성 및 폐경기 여성에게 효과적이라는 보고가 있다. Pueraria lobata (Puerariae radix) is a bark of roots and has no smell. It has been used in Asia for over 1000 years as a maternal herb to reduce heat and remove toxic substances from the body. It directly inflates blood vessels and reduces peripheral resistance to lower blood pressure and alleviate the rigid symptoms of hypertension. Recent studies have shown that they have anti - cancer and estrogen - like effects and can be used as natural breast augmentation and cosmetic products, which is effective for middle - aged women and menopausal women.
산수유(학명 Cornus officinalis, 영문 Cornus) 과일은 다른 약제와 함께 사용될 때 자신과 상대 약제의 효능을 강력하게 드러내는 것으로 알려져 있다. 당뇨병과 관절염, 발기부전 치료에 사용한다. 무릎을 강화하고 체액을 조절하거나 생리불순의 치료를 위해 사용하기도 한다. 나무 껍질은 삶아서 얻는 수렴제는 발열과 말라리아 방지제로 사용된다.Cornus officinalis (Cornus officinalis) Cornus officinalis (Cornus officinalis), when used with other medicines fruit is known to strongly expose the efficacy of the drug itself and the relative. Used for the treatment of diabetes, arthritis and impotence. It can also be used to strengthen the knee, to control body fluids, or to treat menstrual irregularities. The astringent obtained by boiling the bark is used as a fever and malaria inhibitor.
작약 뿌리(학명 Paeonia lactiflora, 영문 Peony Root)는 높은 영양 가치 때문에 수세기 동안 아시아에서 식품과 의약품으로 사용되었다. 뿌리에는 항균, 항곰팡이, 항알레르기, 진통제, 항응고제 및 진정 작용 등이 뛰어난 것으로 알려져 있다. 플라보노이드, 탄닌, 프로 안토시아니 딘, 아스파라기, 시토스테롤, 글리코시드 및 모노테르펜이 포함되어 있다. 근육경련완화, 피부건강, 혈관손상 및 염증 완화, 간염증 예방 등에 사용한다.Peony root (scientific name Paeonia lactiflora, English Peony Root) has been used as food and medicine in Asia for centuries because of its high nutritional value. The roots are known to have excellent antibacterial, antifungal, antiallergic, analgesic, anticoagulant and sedative effects. Flavonoids, tannins, proanthocyanidins, asparagines, sitosterols, glycosides and monoterpenes. Muscle relaxation, skin health, vascular injury and inflammation, and prevention of liver inflammation.
맥주효모(brewer's yeast)는 1 (티아민), B2 (리보플라빈), B3 (니아신), B5 (판토텐산), B6 (피리독신), B9 (엽산), H 또는 B7 (비오틴)이 있다. 이 비타민은 몸에 에너지를 공급하는 탄수화물, 지방 및 단백질을 분해하는 데 도움을 준다. 신경계를 지원하고 소화에 사용되는 근육을 유지하며 피부, 머리카락, 눈, 입 및 간을 건강하게 유지하는데 기여한다. 혈당 수준을 낮춰 내당능을 향상시켜 당뇨병의 관리와 치료에 도움이 되며, 콜레스테롤 수치를 낮추면서 체중 감량에도 도움을 준다.Brewer's yeast contains 1 (thiamine), B2 (riboflavin), B3 (niacin), B5 (pantothenic acid), B6 (pyridoxine), B9 (folate), H or B7 (biotin). These vitamins help break down carbohydrates, fats and proteins that supply energy to the body. Supports the nervous system, maintains the muscles used for digestion, and contributes to keeping the skin, hair, eyes, mouth and liver healthy. By lowering the blood sugar level, it improves the glucose tolerance and helps the management and treatment of diabetes. It also helps to lose weight by lowering the cholesterol level.
오갈피나무 뿌리(학명 Eleutherococcus sessiliflorus, 영문 eleuther)는 수천년 동안 아시아 지역에서 약용으로 사용되고 있고 지난 백년간 서양에 더욱 널리 알려지기 시작한 약용식물이다. 면역시스템을 강화시켜 질병 초기의 각종 증상과 염증 반응을 줄이며 신진대사 촉진, 피로감소로 신경계의 활성과 에너지 수준을 향상시킨다. 최근의 연구에서 오갈피나무 뿌리는 감염된 부위의 통증을 줄인다는 보고가 있으며 이는 골관절염이나 통풍과 같은 염증성 질환에 효과가 있다는 전통적인 사용목적의 과학적 근거로 되고 있다.The root of the eucalyptus tree (Scientific name Eleutherococcus sessiliflorus, English eleuther) has been used medicinally in Asia for thousands of years and has become a more widely known medicinal plant in western Europe over the past 100 years. It strengthens the immune system and reduces various symptoms and inflammation reaction in the early stage of disease. It stimulates the metabolism and reduces the fatigue and improves the activity and energy level of the nervous system. In recent studies, it has been reported that the root of the oak tree reduces the pain of the infected area, which is a scientific basis for traditional use that is effective for inflammatory diseases such as osteoarthritis and gout.
상기와 같이 천연한방복합재료와 닭흉부연골 추출분말의 복합분말이 포함한 조성물은 일반적으로 널리 알려진 닭발, 돼지껍데기, 족발 등에 비해 콜라겐의 흡수율이 매우 높아 골관절염의 예방과 연골 재생에 효과가 있으며, 어묵의 형태로 섭취함으로서 다양한 조리가 가능해져 낮은 열량의 고단백질 식품형태로 건강하게 맛있게 즐길 수 있다.As described above, the composition containing the composite material of the natural herbal composite material and the chest chest cartilage extract powder has a very high absorption rate of collagen than the widely known chicken legs, pig shells, and foot pads, and thus is effective for prevention of osteoarthritis and cartilage regeneration. It can be cooked variously, and it can be enjoyed deliciously in a healthy and high-protein food form of low calories.
본 발명은 상기 천연한방복합재료와 닭흉부연골 추출분말을 포함하는 어묵과 그 제조방법을 제공하는데 그 목적이 있다.It is an object of the present invention to provide a fish paste including the natural herbal composite material and the chest chest cartilage extract powder and a method for producing the same.
콜라겐은 글리코사미노글리칸(Glycosaminoglycans, GAGs 또는 뮤코다당)과 단백질로 구성되며, 음전하를 띤 3차원 선형구조로 관절세포 내 수분 조절, 마그네슘, 칼슘, 인 등의 무기질의 이동 매개체로 작동하면서 골 대사기능에 관여한다. 특히 유기체인 해면골 부분에서 매우 중요하며, 세포내 안정화를 위한 바이러스 또는 박테리아에 대해 염증을 방어하는 작용을 한다. 신체 각 관절의 연골은 약 60~80%의 수분과 15 ~ 20%의 콜라겐, 그리고 3 ~ 5%의 글루코사민과 콘드로이틴, 그리고 히알루론산으로 구성되어 있다.Collagen is composed of glycosaminoglycans (GAGs or mucoadas glycans) and proteins. It is a three-dimensional linear structure with a negative charge. It acts as a transport medium of mineral such as magnesium, calcium, phosphorus, It is involved in bone metabolic function. It is especially important in the organelles, the cancellous bone, and acts to defend inflammation against viruses or bacteria for intracellular stabilization. The cartilage of each joint in the body consists of about 60-80% water, 15-20% collagen, 3-5% glucosamine and chondroitin, and hyaluronic acid.
일반 식품 중에서도 닭발, 돼지껍데기, 족발에 풍부하게 포함되어 있다고 알려져 있지만 대부분 소화과정에서 아미노산 수준으로 분해되어 흡수되고 그중 극히 일부만이 콜라겐 합성에 이용되고 있어 효율성이 매우 낮다. 노화방지에 대한 자연스러운 욕구와 콜라겐 함량이 높다고 알려진 식품에 대한 정보가 결합해서 1회 섭취 만으로 1일 권장 섭취열량을 훨씬 뛰어넘는 고열량의 닭발, 돼지껍데기, 족발 등을 섭취해서 콜라겐 섭취를 위해 비만을 유발하는 역설적인 상황이 일상적으로 나타나고 있다.Although it is known that it is abundantly contained in chicken legs, pig shells, and paws among general foods, most of them are decomposed and absorbed into amino acid level during digestion process, and only very few of them are used for collagen synthesis. Combined with a natural need for anti-aging and information on foods that are known to have high collagen content, it is recommended to take only one serving daily. High calorie foods such as high-calorie chickens, pig shells, and paws that go far beyond calories are recommended for obesity The paradoxical situation that leads to this is everyday.
비만을 유발하는 식품을 통해 저효율의 콜라겐을 섭취하는 현재의 역설적인 상황을 해결하기 위해 현재 식용 가능한 천연추출 콜라겐 중에서 체내 흡수율이 가장 높은 것으로 확인된 비변성2형 콜라겐의 주요 재료로서 닭흉부연골 분말을 사용한다. 비변성2형 콜라겐과 체내 콜라겐의 흡수와 재생을 돕는 천연한방복합재료를 보호하고 편리하게 섭취하는 방법으로서 고단백 저지방 식품인 어묵을 활용한다.In order to solve the present paradoxical situation of consuming low-efficiency collagen through foods that induce obesity, Chicken Chest Cartilage Powder as a main material of non-denatured type 2 collagen which has been found to have the highest absorption rate in the body among natural edible collagen, Lt; / RTI > It uses a high-protein low-fat fish paste (fish paste) as a method to protect and conveniently ingest a natural herbal composite which helps absorption and regeneration of non-modified type 2 collagen and body collagen.
본 발명에 의하면 어묵의 형태로 질높은 비변성2형 콜라겐과 약제학적 조성물을 섭취함으로서 닭발, 돼지껍데기 또는 족발처럼 비만을 유발하지 않고 편리하고 맛있게 건강을 위한 식품을 즐길 수 있다.According to the present invention, by eating high quality non-denatured type 2 collagen and pharmaceutical composition in the form of fish cake, it is possible to enjoy convenient and delicious food for health without inducing obesity such as chicken legs, pig shells or foot paws.
비변성2형 콜라겐을 함유한 속재료와 속재료를 보호하는 어묵살로 만들어진 어묵의 단면
1 - 속재료 : 고구마 또는 감자 무스에 닭흉부연골 추출분말, 천연한방복합재료 분말과 벌꿀을 반죽한 조성물
2 - 겉껍질 : 어육반죽으로 만든 어묵살A cross-section of a fish cake made of fish cake containing a non-modified type 2 collagen and ingredients to protect the ingredients
1 - Ingredients: Chicken chest cartilage extract powder in potato or potato mousse, Composition kneaded with natural herbal composite powder and honey
2 - Crust: fish paste made from fish paste
본 발명의 목적을 달성하기 위하여 닭흉부연골 추출분말과 양파, 갈대 뿌리, 구기자 열매, 개다래나무 열매, 박하 잎, 갈근, 길초근, 산수유 열매, 작약 뿌리, 맥주 효모, 오갈피나무 뿌리의 건조분말을 각각 선별하여 준비하고 찐감자를 으깬 무스 또는 찐고구마를 으깬 무스에 섞은 후 꿀벌을 추가하여 천연한방복합 반죽을 길죽한 막대모양으로 성형하여 그 형태가 유지가능한 정도의 점성으로 속재료로 준비한다. 이렇게 준비한 속재료를 히알루로니데이즈의 활성화를 측정하고 인체적용시험으로 피부 탄력시험과 피부 주름억제 시험을 수행하는 한편, 실험 동물의 골밀도와 탄성력을 측정하여 관찰한 결과 본 발명에 따른 속재료가 항노화와 관절염 증상을 완화시킬 수 있음을 확인하였다.In order to achieve the object of the present invention, the chest chest cartilage extract powder and the dried powder of onion, reed roots, ginger fruit, ganoderma lucidum, peppermint leaves, Prepare them separately and mix them with mashed mush or mashed steamed sweet potatoes, and then add honey bees to form the kneaded mixture of natural herb complexes into a sticky bar shape. The ingredients thus prepared were measured for activation of hyaluronidase, skin elasticity test and skin wrinkle inhibition test were conducted by human body test, and the bone mineral density and elasticity of the experimental animals were measured and observed. As a result, It was confirmed that the symptoms of arthritis can be alleviated.
본 발명은 닭흉부연골 추출분말과 벌꿀 그리고 양파, 갈대 뿌리, 구기자 열매, 개다래나무 열매, 박하 잎, 갈근, 길초근, 산수유 열매, 작약 뿌리, 맥주 효모, 오갈피나무 뿌리의 건조분말로 이루어진 조성물을 함유하는 약제학적 조성물과 이 조성물이 포함된 감자 무스 또는 고구마 무스를 속재료로 하고 속재료를 어묵 반죽으로 완전히 밀봉하여 감싼 후 찌거나 굽거나 튀겨서 익혀 식품화된 어묵을 제공한다.The present invention relates to a composition comprising chickens chest cartilage extract powder and honey, and dried powder of onion, reed roots, ginger fruit, ganoderma powder, mint leaf, purlins, gill root, corn oil, peony root, brewer's yeast, And a potato mousse or sweet potato mousse containing the composition as a starting material, and the ingredients are fully sealed with a fish paste and then cooked, roasted or fried to provide a foodstuffed fish paste.
본 발명에 있어서 상기 어묵의 구성물 중 속재료에 사용된 닭흉부연골 추출분말과 양파, 갈대 뿌리, 구기자 열매, 개다래나무 열매, 박하 잎, 갈근, 길초근, 산수유 열매, 작약 뿌리, 맥주 효모, 오갈피나무 뿌리로 구성된 조성물은 항노화 및 관절 염증 개선용 식품 조성물을 제공한다.In the present invention, the chick breast cartilage extract powder used in the ingredients of the fish paste according to the present invention and onion, reed roots, goji berries, ganoderma lucidum, peppermint leaves, pruning roots, The composition consisting of roots provides a food composition for improving anti-aging and joint inflammation.
본 발명에 있어서 상기 어묵의 속재료 중 찐감자 무스 또는 찐고구마 무스를 제외한 조성물이 닭흉부연골 추출분말 10~40중량%, 벌꿀 1~20중량%, 양파 1~10중량%, 갈대 뿌리 1~10중량%, 구기자 열매5~20중량%, 개다래나무 열매5~15중량%, 박하 잎1~10중량%, 갈근 1~10중량%, 길초근 5~15중량%, 산수유 열매 5~10중량%, 작약 뿌리5~10중량%, 맥주 효모 1~10중량%, 오갈피나무 뿌리 5~10중량%로 구성된 것을 특징으로 한다.In the present invention, the composition of the ingredients of the fish paste except for the chewing gum mousse or steamed sweet potato mousse contains 10 to 40% by weight of the chest chest cartilage extract powder, 1 to 20% by weight of honey, 1 to 10% by weight of onion, 1 to 10% 5 to 15% by weight of ganoderma powder, 5 to 15% by weight of ganoderma powder, 1 to 10% by weight of mint leaf, 1 to 10% 5 to 10% by weight of peanut root, 1 to 10% by weight of brewer's yeast, and 5 to 10% by weight of root root.
[실시예][Example]
이하 본 발명의 바람직한 실시예를 제시한다. 하기의 실시예는 본 발명의 이해를 돕기 위하여 제시되는 한 예일뿐 본 발명이 하기의 실시예에 한정되는 것은 아니다.Hereinafter, preferred embodiments of the present invention will be described. The following examples are provided to aid understanding of the present invention, but the present invention is not limited to the following examples.
<실시예 1 ~ 5. 본 발명에 따른 항노화 및 관절 염증 치료용 속재료의 제조><Examples 1 to 5> Preparation of Ingredients for Anti-Aging and Joint Inflammation Treatment According to the Present Invention>
상기 표1의 비율에 따라 양파 1~10중량%, 갈대 뿌리 1~10중량%, 구기자 열매5~20중량%, 개다래나무 열매5~15중량%, 박하 잎1~10중량%, 갈근 1~10중량%, 길초근 5~15중량%, 산수유 열매 5~10중량%, 작약 뿌리5~10중량%, 맥주 효모 1~10중량%, 오갈피나무 뿌리 5~10중량%의 건조약재를 분쇄기로 파쇄하여 균질하게 혼합하였다. 그런 다음 닭흉부연골 추출분말 10~40중량%, 을 가하여 균질하게 혼합하였다. 이렇게 준비된 혼합분말을 찐감자을 식힌 후 으깬 무스에 넣고 혼합분말100중량%에 무스 100중량% 비율로 반죽하듯 혼합하고 마지막으로 벌꿀 1~20중량%을 넣고 반죽하듯 혼합하여 속재료를 준비하였다.1 to 10 wt% of onion, 1 to 10 wt% of reed roots, 5 to 20 wt% of ginger root, 5 to 15 wt% of ginkgo nut, 1 to 10 wt% of mint leaves, 1 to 10 wt% of ginger root, Dried pellets of 5 to 10 wt.%, Gill root 5 to 15 wt.%, Corn oil 5 to 10 wt.%, Peanut root 5 to 10 wt.%, Brewer's yeast 1 to 10 wt. And homogenously mixed. Then, 10 to 40% by weight of chest chest cartilage extract powder was added and mixed homogeneously. The thus prepared mixed powder was cooled, and the resulting mixture was put in a mashed mousse. The mixture was mixed with 100% by weight of a mixed powder in a ratio of 100% by weight, and finally mixed with 1 to 20% by weight of honey to prepare a starting material.
벌꿀은 속재료 전체의 성형을 수월하게 하고 벌꿀 특유의 살균과 항균 작용으로 유통과정에서 속재료의 변질을 방지하기 위한 목적으로 속재료 자체의 점성을 적정하게 유지하기 위해 상기 표1의 비율보다 다소 더 많거나 적을 수 있으며, 이는 제조하는 날의 습도와 온도에 영향을 받는다.Honey is more or less than the ratio shown in the above Table 1 in order to maintain the viscosity of the starting material itself properly for the purpose of facilitating the molding of the entire material and preventing the deterioration of the ingredients in the distribution process due to the sterilization and antibacterial action peculiar to honey Which is influenced by the humidity and temperature of the blade to be manufactured.
준비된 속재료를 반죽의 형태로 만들어진 어묵살로 완전히 밀봉하여 감싸도록 성형하여 150°C∼180°C의 대두유에서 튀겨냈다. 이때 일반적인 어묵반죽 100%의 완전한 어묵을 튀길 때보다 시간을 짧게하여 속재료에 가해지는 열을 최소화하였다.The prepared ingredients were foamed in soy sauce oil at 150 ° C to 180 ° C, wrapped completely in a hermetically sealed kelp flesh in the form of dough. At this time, the time was shortened when compared to the case of frying a complete fish cake of general 100% fish paste to minimize the heat applied to the ingredients.
<비교예 1>≪ Comparative Example 1 &
실시예 1과 동일하게 실시하되 혼합분말 100중량%에 무스 200중량%로 반죽하고벌꿀 1~20중량%을 넣고 혼합하였다.The same procedure as in Example 1 was carried out except that 100% by weight of the mixed powder was kneaded to 200% by weight of mousse and 1 to 20% by weight of honey were mixed and mixed.
<비교예 2>≪ Comparative Example 2 &
실시예 1과 동일하게 실시하되 혼합분말 100중량%에 무스 300중량%로 반죽하고벌꿀 1~20중량%을 넣고 혼합하였다.The same procedure as in Example 1 was carried out except that 100% by weight of the mixed powder was kneaded to 300% by weight of mousse and 1 to 20% by weight of honey were mixed and mixed.
<비교예 3>≪ Comparative Example 3 &
실시예 1과 동일하게 실시하되 혼합분말 100중량%에 무스 400중량%로 반죽하고벌꿀 1~20중량%을 넣고 혼합하였다.The same procedure as in Example 1 was carried out except that 100% by weight of the mixed powder was kneaded into 400% by weight of mousse and 1 to 20% by weight of honey was mixed and mixed.
<평가 1 : 속재료의 조성분말 비율에 따른 속재료의 점성 변화>≪ Evaluation 1: Change in viscosity of the ingredient according to the composition ratio of the ingredients < RTI ID = 0.0 >
동일한 무스 중량에 속재료의 조성분말 성분비율의 변화는 완성된 속재료 자체의 점성에 큰 영향을 미치지 않으며, 벌꿀이 전혀 들어가지 않은 상태에서는 오히려 속재료가 푸석푸석해지는 경향이 있어 속재료의 성형과 형태 유지가 힘들어지므로 살균과 유통안전성뿐 아니라 완제품의 시각적 완성도를 위해서라도 적정량의 벌꿀은 반드시 포함되어야 함을 알 수 있었다.Composition of Ingredients in the same Moist Weight The change of the powder component ratio does not have a great influence on the viscosity of the finished material itself, and when the honey does not enter at all, the ingredient material tends to become rough, It was found that honey should be absolutely included even for sterilization and distribution safety as well as visual completeness of the finished product.
<평가 2 : 고구마 무스 중량변화에 따른 완제품의 향 변화><Evaluation 2: Variation of flavor of finished product according to weight change of sweet potato mousse>
본원 발명에 의한 제품은 속재료의 특성상 한약재료 특유의 향이 날 수 있는데, 완제품에서 실시예 1의 경우에는 분명한 한약재 향과 감자의 맛이 함께 느껴지지만, 무스의 함량이 높아질 수록 한약재 향이 옅어지는 것을 확인할 수 있었다. 1회 섭취량에 포함되는 비변성2형 콜라겐과 한방복합재료의 분량에 대한 더욱 면밀한 검토와 계산이 필요하겠으나, 무엇보다 본원 발명품의 목적과 효능을 생각할 때 자연스럽게 약간의 한약재의 향이 나도록 만들어 본원 발명에 의한 어묵을 먹는 사람들이 특별한 제품임을 인식하도록 하는 것도 유용할 것이다.The product according to the present invention has a characteristic flavor of the herbal medicine material in the nature of the ingredient. In the case of Example 1, the clear herbal medicine flavor and the potato flavor are felt together with the finished product, but the aroma of the herb medicine is lessened as the content of the mousse is higher I could. The amount of non-modified 2-type collagen and herbal composite materials included in the single dose should be further examined and calculated. However, considering the purpose and efficacy of the present invention, It is also useful to let people who eat fish cake by hand recognize that it is a special product.
<실험예 1. 본 발명에 의한 속재료 조성물의 히알루로니데이즈 활성 억제도 측정 >EXPERIMENTAL EXAMPLE 1 Measurement of Inhibition of Hyaluronidase Activity of Component Material Composition According to the Invention [
히알루론산(hyaluronic acid)은 생체 내 연골조직에 많이 함유되어 있는 물질로, 연골조직의 탄력성을 높이는데 큰 역할을 하며, 수분 함유량이 높고, 뛰어난 점탄성(viscoelasticity)을 지니고 있다. 일반적으로 골관절염 환자에게서 히알루론산의 분해 촉진이 관찰되고 있다. 히알루로니데이즈(hyaluronidase) 등이 관절연골세포의 세포사를 증가시키고, 연골세포의 대사작용을 감소시켜 연골조직의 퇴행성 변화를 촉진한다는 연구보고가 있다. 따라서, 히알루론산의 분해효소인 히알루로니데이즈를 억제하면 골관절염의 치료효과 가능성이 있을 것으로 생각된다.Hyaluronic acid is a substance contained in many cartilage tissues in vivo, plays a major role in improving the elasticity of cartilage tissue, has high moisture content, and has excellent viscoelasticity. In general, accelerated degradation of hyaluronic acid is observed in osteoarthritis patients. There are reports that hyaluronidase and the like increase the cell death of articular cartilage cells and decrease the metabolism of cartilage cells to promote degenerative changes of cartilage tissue. Therefore, inhibition of hyaluronidase, which is a degradative enzyme of hyaluronic acid, is thought to be a therapeutic effect of osteoarthritis.
본 발명 혼합물의 히알루로니데이즈 활성 억제도를 알아보기 위하여, Morgan-Elson Assay 법을 이용하여 활성을 측정하였다. 인산완충용액에 녹인 히알루론산과 DMSO에 녹인 상기 실시예에서 제조한 추출 혼합물을 각각 넣고 37℃에서 20분간 배양하였다. 배양한 후에 화합물 48/80용액을 넣고 2차 배양하였다. 히알루론산을 넣고 3차 배양 한 후 K3BO3를 넣고 열탕에서 가열하여 반응을 중지시켰다. 원심분리 후, 히알루론산이 히알루로니데이즈에 의해서 분해되어 생성되는 N-알세틸글루코사민(N-acetylglucosamine)을 DMAB(p-dimetylaminobenzaldehyde)를 이용하여 585㎚에서 비색정량하여 활성을 검증하였다. 양성 대조군으로 셀레콕시브(celecoxib, Pfizer)를 사용하였다.In order to examine the hyaluronidase activity inhibition of the mixture of the present invention, the activity was measured using the Morgan-Elson Assay method. Hyaluronic acid dissolved in phosphate buffer solution and the extract mixture prepared in the above example dissolved in DMSO were added to each well and cultured at 37 ° C for 20 minutes. After incubation, the compound 48/80 solution was added and secondary cultured. After hyaluronic acid was added and cultured for the third time, K3BO3 was added and the reaction was stopped by heating in hot water. After centrifugation, N-acetylglucosamine, which is produced by degradation of hyaluronic acid by hyaluronidase, was quantified by colorimetry at 585 nm using DMAB (p-dimethylaminobenzaldehyde), and its activity was verified. Celecoxib (Pfizer) was used as a positive control.
결과는 표 2에 나타내었다.The results are shown in Table 2.
표 2에 나타난 바와 같이, 본 발명의 혼합물 중 실시예 3은 히알루로니데이즈의 활성 억제도가 63.9±0.47 %로, 양성대조군 셀레콕시브 활성 억제도 62.7±0.38 비슷하거나 약간 높게 나와 다른 실시예와 비교하여 억제효과가 높음을 관찰 할 수 있었다.As shown in Table 2, in Example 3 of the mixture of the present invention, the activity inhibition of hyaluronidase was 63.9 ± 0.47% and the inhibition of positive control celecoxib activity was 62.7 ± 0.38, And the inhibition effect was high.
<실험예 2. 본 발명에 의한 속재료 조성물의 피부 탄력 시험>Experimental Example 2 Skin Elasticity Test of Ingredient Composition According to the Present Invention [
실시예 1 및 3에 의해 제조된 혼합물로 피부 탄력효과를 측정하였다. 측정방법은 25℃, 상대습도 50%, 항온항습 조건의 실내에서, 피부질환이 없는 건강한 여성 10명을 대상으로 눈꼬리(crows feet)부위에서 좌,우로 나눈 후, 피험자 번호순으로 좌측부위에는 실시예 1을, 우측 부위에는 실시예 3를 4주간, 하루에 녹두대알 크기의 환을 8 그람씩 소분화 포장하여 나누어 주고 아침 식사 30분 전에 섭취하게 하였다. 탄력상태에 대한 피부 탄력도 평균 값을 Cutometer MPA580 (Courage and Khazaka, Kiln, Germany)으로 피부의 탄력정도를 측정하였다.Skin elasticity effects were measured with the mixtures prepared according to Examples 1 and 3. The measurement method was as follows: 10 healthy women without skin disease were divided into left and right crows feet at 25 ° C, 50% relative humidity and room temperature and humidity conditions. 1, on the right side, Example 3 was divided into small portions of 8 grams of mung bean egg size per day for 4 weeks, and divided into 30 minutes before breakfast. The elasticity of the skin was measured by Cutometer MPA580 (Courage and Khazaka, Kiln, Germany).
측정장비에서 R2 값은 피부의 재변형 능력으로 총체적인 탄성(gross elasticity)을 의미한다. 실시예 1은 R2값이 측정결과 13.6% 증가하였고, 실시예 3는 R2값이 측정결과 18.9% 증가하여 피부 탄력 증가에 효과가 있음을 관찰하였다.The R2 value in the measuring equipment means the gross elasticity of the skin due to the ability to re-deform the skin. In Example 1, the R2 value was increased by 13.6% in the measurement result, and in Example 3, the R2 value was increased by 18.9% in the measurement result, and the skin elasticity was increased.
< 실험예 3 : 본 발명에 의한 속재료 조성물의 피부 주름 시험 ><Experimental Example 3: Skin wrinkle test of ingredient material composition according to the present invention>
실시예3으로 제조된 혼합물로 피부주름효과를 측정하였다. 측정방법은 25℃, 상대습도 50%, 항온항습 조건의 실내에서, 피부질환이 없는 건강한 여성 10명을 대상으로 눈꼬리(crows feet) 부위에서 좌,우로 나눈 후, 피험자 번호순으로 좌측부위 5명, 우측부위 5명을 선정하고, 6주간, 하루에 녹두대알 크기의 환을 8 그람씩 소분화 포장하여 나누어 주고 아침 식사 30분 전에 섭취하게 하였다.주름상태에 대한 피부 주름 부위에 모사판(Replica)을 제작한 후 Visiometer (Skin-Visiometer SV 600, Courage & Khazaka, Germany)를 이용하여 피부주름 모사판(Replica)에 대한 화상분석(Image Analysis)을 시행함으로써 피부주름의 변화를 분석하였다.The wrinkle effect of the skin was measured with the mixture prepared in Example 3. The subjects were 10 healthy women without skin disease at 25 ℃, 50% relative humidity and room temperature and humidity condition. The subjects were divided into left and right eyes at the crows feet, The rats were divided into two groups of 8 grams of green bean sprout sized for 6 weeks and divided into two groups and fed 30 minutes before breakfast. And then analyzed for skin wrinkles by performing image analysis on replica skin using Visiometer (Skin-Visiometer SV 600, Courage & Khazaka, Germany).
R3값은 Average Roughness를 의미 한다. 즉 평균적으로 주름의 깊이에 관련된 직접적인 Parameter이므로 R3값의 6주(0.181)와 0주(0.232)의 차이값 -0.051 감소하였으므로 주름개선 효과 차이가 있다는 것을 관찰하였다.R3 value means Average Roughness. In other words, it is a direct parameter related to the depth of wrinkles. Therefore, it was observed that there was a difference in the wrinkle-improving effect because the difference between -0.05 and -0.051 in the R3 value was decreased from 6 weeks (0.181) to 0 week (0.232).
< 실험예 4 : 본 발명에 의한 속재료 조성물의 동물 효과 시험 >EXPERIMENTAL EXAMPLE 4: Animal Effect Test of Ingredient Composition According to the Present Invention [
본 발명의 혼합물의 골밀도와 골생체지수인 탄성력 효과를 확인하기 위하여 하기와 같은 실험을 수행하였다.The following experiment was conducted to confirm the effect of the elasticity of the bone mineral density and the bone bioindex of the mixture of the present invention.
실험동물로 체중 240~260g의 10마리 쥐를 무작위로 5마리씩 2개 그룹으로 나눈다. 음성 대조군 (난소 절제 쥐, 기본먹이 4000mg/kg 칼슘함유 단백질), 시험군으로 (난소 절제 쥐, 실시예3 혼합물먹이 10g/kg)으로 구성된다. 1주일 적응기간 후 2% 소듐 펜토바비톨 용액으로 복강주사로 마취하고 양 난소를 절제한다. 수술후 2일 후에 질내 검사로 테스트를 한후 5일이 지나서 발정주기를 확인하여 성공여부를 확인한다. 수술 1주일 후 8주간 음성대조군에는 기본 먹이(4000mg/kg 칼슘함유이 함유된 단백질 10g/kg)를 시험군에는 실시예 3 혼합물을 10g/kg)를 경구 투여하였다. 8주 시험한 후 쥐를 해부하여 대퇴부 주변 조직을 제거하여 오른쪽 대퇴부와 경골를 필링해낸다. 그리고 영하 70도에 보관한다. 경골은 생리식염수로 함침된 거즈에 보관한다. 1일 후 골밀도 및 탄성력를 시험한다.As experimental animals, 10 rats weighing 240-260 g are randomly divided into two groups of 5 rats each. A negative control (ovariectomized rats, protein containing 4000 mg / kg calcium base) and a test group (ovariectomized rats, 10 g / kg feed of Example 3). After an adaptation period of one week, anesthetize with 2% sodium pentobarbitol solution by intraperitoneal injection and excision of both ovaries. Two days after the operation, the vaginal test is performed. After 5 days, the vaginal interval is checked and the success is confirmed. (1 g / kg of protein containing 4000 mg / kg of calcium) in a negative control for 8 weeks after one week of operation, and 10 g / kg of the mixture of Example 3 in the test group. After 8 weeks of testing, the mice are dissected and the surrounding thigh tissue is removed to fill the right femur and tibia. And keep it at minus 70 degrees. The tibia is kept in gauze impregnated with physiological saline solution. Test bone density and elasticity after 1 day.
대퇴부 뼈 골밀도는 대조군(1.201±0.051)에 비하여 실시예 3은 (1.245±0.037)으로 3.66% 증가하였으며 탄성력은 대조군 (307.2±59.7)에 비하여 실시예 3은 (425.7±238.1)으로 38.57% 탄성력이 증가하여 관절에 효과를 나타냄을 알 수 있다.The bone mineral density of the thigh bone was increased by 3.66% in Example 3 (1.245 ± 0.037) compared to the control (1.201 ± 0.051), and elasticity was 38.57% elasticity in Example 3 (425.7 ± 238.1) compared to the control (307.2 ± 59.7) And the effect is shown on the joints.
이상에서와 같이 본원 발명은 비변성2형 콜라겐의 핵심원료인 닭흉부연골 추출분말과 한방복합재료를 생활속에서 쉽고 편리하게 섭취할 수 있도록 대중적으로 애용하는 식품인 어묵의 형태로 공급함으로서써, 고급 어묵 시장의 새로운 건강 웰빙식품으로 노화예방, 피부피용, 건강관리에 효과가 있는 것이어서 국민 건강증진에 기여하는 유용한 발명품이다.
상기 발명의 상세한 설명은 단지 본원발명의 예시적인 것으로서, 이는 단지 본원발명을 설명하기 위한 목적에서 사용된 것이지 의미 한정이나 특허청구범위에 기재된 본원발명의 범위를 제한하기 위하여 사용된 것은 아니다.
그러므로 이 기술분야의 통상의 지식을 가진 자 라면 이로부터 다양한 변형 및 균등한 타 실시예가 가능하다는 점을 이해할 것이다.
따라서 본원발명의 진정한 기술적 보호 범위는 첨부된 특허청구범위의 기술적 사상에 의해 정해져야 할 것이다.As described above, the present invention provides chickens chest cartilage extract powder and a herbal composite material, which are core raw materials of non-modified type 2 collagen, in the form of fish paste, which is a popular food for easy and convenient ingestion in daily life, It is a new healthy wellbeing food in the fine fish paste market. It is effective for prevention of aging, skin abuse, and health care. It is a useful invention contributing to the promotion of public health.
The detailed description of the invention is merely exemplary of the invention, which is used for the purpose of describing the invention only, and is not used to limit the scope of the invention as defined in the claims or the claims.
It is therefore to be understood that various modifications and equivalents may be resorted to by those skilled in the art.
Accordingly, the true scope of the present invention should be determined by the technical idea of the appended claims.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170096218A KR20190012743A (en) | 2017-07-28 | 2017-07-28 | Fish cake contained undenatured collagen type II and manufacturing method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170096218A KR20190012743A (en) | 2017-07-28 | 2017-07-28 | Fish cake contained undenatured collagen type II and manufacturing method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20190012743A true KR20190012743A (en) | 2019-02-11 |
Family
ID=65370556
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020170096218A KR20190012743A (en) | 2017-07-28 | 2017-07-28 | Fish cake contained undenatured collagen type II and manufacturing method thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20190012743A (en) |
-
2017
- 2017-07-28 KR KR1020170096218A patent/KR20190012743A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103689296B (en) | Feed for ewe at later pregnancy and lactation period and preparation method thereof | |
CN109123643A (en) | A kind of preparation method of cereal generation meal ball | |
KR101738912B1 (en) | Composition For Anti-obesity And Diet | |
CN110771880A (en) | Blood sugar-reducing quinoa meal replacement powder and preparation process thereof | |
CN110447902B (en) | Composition with weight-losing effect | |
KR100448260B1 (en) | Processing Methods of Health Food for the Control of Body Weight | |
CN101579120A (en) | Nutritional food with weight-losing function and preparation method thereof | |
CN107373672A (en) | A kind of irregular menstruation women tailored version clinical nutrition formula and preparation method thereof | |
CN105124276A (en) | Feed for raising crabs | |
KR102265866B1 (en) | Manufacturing method of extract from sulfur-fed duck for preventing or improving of diabetes | |
KR101642176B1 (en) | Composition for enhancing growth and reinforcing immunity | |
RU2333677C2 (en) | Dietary supplement | |
CN102652561A (en) | Vegetable protein food for treating micro-disease or assisting medicament in rehabilitating sick body and production method thereof | |
KR20120095505A (en) | Foot-and-mouth disease prevention useful feed and method of preparing thereof | |
KR100503208B1 (en) | Diet-food composition | |
KR20180126691A (en) | Oriental pills for the prevention, improvement or treatment of arthritis and methods for producing the same | |
KR20090038595A (en) | Healthy filling composite for korea tradition sausage and korea tradition sausage process using the same | |
Masihuzzaman et al. | Badam shireen (Prunus dulcis Mill): A ghiza-e-dawaee and immunomodulator: A latest review | |
KR20190012743A (en) | Fish cake contained undenatured collagen type II and manufacturing method thereof | |
CN103181557A (en) | Nutritious food with slimming function and preparation method thereof | |
CN111972656A (en) | Mushroom sauce and preparation method thereof | |
CN109620858A (en) | The integration of drinking and medicinal herbs preparation for preventing and treating diabetes | |
CN109481605A (en) | A kind of drug for the treatment of cancer of combatting poison with poison and the preparation method of a variety of anti-cancer therapies | |
KR20190101632A (en) | Anti-inflammatory composition containing medicinal herbs | |
CN103300363B (en) | Anti-fatigue traditional Chinese medicine capsule and preparation method thereof |